# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-007622
Filing Date
2020-01-28
Accepted
2020-01-28 15:29:21
Documents
6
Period of Report
2020-03-19
Effectiveness Date
2020-01-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm205992-1_def14a.htm | DEF 14A | 422527
2 | GRAPHIC | tm205992-1_def14aimg0001.jpg | GRAPHIC | 6881
3 | GRAPHIC | tm205992-1_def14aimg0002.jpg | GRAPHIC | 9081
4 | GRAPHIC | tm205992-1_def14aimg0003.jpg | GRAPHIC | 7369
5 | GRAPHIC | card-01.jpg | GRAPHIC | 326584
6 | GRAPHIC | card-02.jpg | GRAPHIC | 225318
| Complete submission text file | 0001104659-20-007622.txt |  | 1216580

Mailing Address 2701 KENT AVENUE WEST LAFAYETTE IN 47906-1382
Business Address 2701 KENT AVE WEST LAFAYETT IN 47906-1382 3174634527
BIOANALYTICAL SYSTEMS INC (Filer) CIK: 0000720154 (see all company filings)

EIN.: 351345024 | State of Incorp.: IN | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-23357 | Film No.: 20554011
SIC: 8731 Services-Commercial Physical & Biological Research